Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Gastrointestinal Motility Disorders01:20

Gastrointestinal Motility Disorders

1.6K
Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
1.6K
Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy01:26

Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy

681
This lesson explores three gastrointestinal imaging techniques: radionuclide testing, colonic transit studies, and virtual colonoscopy.
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and...
681
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

59
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
59
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

36
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH...
36
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

49
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence...
49
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

33
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor,...
33

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk factors for severe delayed postpolypectomy bleeding.

Endoscopy·2008
Same author

FOBT is not an effective way to screen for gastric cancer.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2007
Same author

Quality in the technical performance of screening flexible sigmoidoscopy: recommendations of an international multi-society task group.

Gut·2005
Same author

Colon polyps and cancer.

Endoscopy·2005
Same author

Update on colorectal polyps: management and follow-up surveillance.

Endoscopy·2003
Same author

Colon polyps and cancer.

Endoscopy·2003
Same journal

How important is fiber in the Crohn's disease story?

Gastroenterology·2026
Same journal

Reply to "Critical Appraisal of the Integrin αV-YAP-CTGF Axis in Congestive Hepatopathy".

Gastroenterology·2026
Same journal

Critical Appraisal of the Integrin αV-YAP-CTGF Axis in Congestive Hepatopathy.

Gastroenterology·2026
Same journal

A High-Risk Impaction: To Scope or to Stent First?

Gastroenterology·2026
Same journal

Epithelial FOXP3 Orchestrates O-Glycosylated IL6 Secretion to Drive Pancreatic Fibrocarcinogenesis.

Gastroenterology·2026
Same journal

Reply.

Gastroenterology·2026
See all related articles

Related Experiment Video

Updated: May 5, 2026

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
04:39

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

2.8K

Gastrointestinal transit in thyroid disease.

R B Shafer, R A Prentiss, J H Bond

    Gastroenterology
    |May 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Thyroid dysfunction significantly impacts gastrointestinal motility. This study found altered gut transit times in hyperthyroid and hypothyroid patients, explaining common digestive issues.

    More Related Videos

    Author Spotlight: Reliable and Reproducible In Vitro Assessment of Drug Impact on Rat Intestinal Tubes
    06:01

    Author Spotlight: Reliable and Reproducible In Vitro Assessment of Drug Impact on Rat Intestinal Tubes

    Published on: July 26, 2024

    1.1K
    Author Spotlight: Integrating Ultrasound Imaging with Biochemical Markers for Thyroid Disease Diagnosis
    05:41

    Author Spotlight: Integrating Ultrasound Imaging with Biochemical Markers for Thyroid Disease Diagnosis

    Published on: February 9, 2024

    1.3K

    Related Experiment Videos

    Last Updated: May 5, 2026

    Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
    04:39

    Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

    Published on: March 17, 2023

    2.8K
    Author Spotlight: Reliable and Reproducible In Vitro Assessment of Drug Impact on Rat Intestinal Tubes
    06:01

    Author Spotlight: Reliable and Reproducible In Vitro Assessment of Drug Impact on Rat Intestinal Tubes

    Published on: July 26, 2024

    1.1K
    Author Spotlight: Integrating Ultrasound Imaging with Biochemical Markers for Thyroid Disease Diagnosis
    05:41

    Author Spotlight: Integrating Ultrasound Imaging with Biochemical Markers for Thyroid Disease Diagnosis

    Published on: February 9, 2024

    1.3K

    Area of Science:

    • Endocrinology
    • Gastroenterology
    • Physiology

    Background:

    • Thyroid dysfunction commonly presents with gastrointestinal symptoms like diarrhea (hyperthyroidism) or constipation (hypothyroidism).
    • Abnormalities in gastrointestinal motility are suspected causes, but previous studies yielded conflicting results, often relying on limited transit time measurements.

    Purpose of the Study:

    • To investigate gastrointestinal transit time in patients with thyroid dysfunction.
    • To correlate altered gut motility with digestive symptoms in hyperthyroidism and hypothyroidism.

    Main Methods:

    • Utilized hydrogen (H2) pulmonary excretion after lactulose ingestion to measure colonic transit time in fasting patients.
    • Compared transit times in hyperthyroid patients, hypothyroid patients, and healthy controls.

    Main Results:

    • Hyperthyroid patients exhibited significantly faster transit times (29 +/- 4.0 min) compared to controls (72 +/- 3.7 min).
    • Following treatment, hyperthyroid patients who became hypothyroid showed slower transit times (80 +/- 11.0 min).
    • Hypothyroid patients demonstrated significantly improved transit times after thyroid hormone replacement therapy.

    Conclusions:

    • Abnormal gastrointestinal motility is a primary factor in the digestive complaints associated with thyroid dysfunction.
    • Faster transit in hyperthyroidism may cause diarrhea and malabsorption.
    • Slower transit in hypothyroidism may lead to constipation and obstipation.